Neural Differentiation of Mouse Embryonic Stem Cells in Serum-free Monolayer Culture

Summary

This protocol describes in detail the method for generating neural progenitors from embryonic stem cells using a serum-free monolayer method. These progenitors can be used to derive mature neural cell types or to study the process of neural specification and is amenable to multiwell format scaling for compound screening.

Abstract

The ability to differentiate mouse embryonic stem cells (ESC) to neural progenitors allows the study of the mechanisms controlling neural specification as well as the generation of mature neural cell types for further study. In this protocol we describe a method for the differentiation of ESC to neural progenitors using serum-free, monolayer culture. The method is scalable, efficient and results in production of ~70% neural progenitor cells within 4 - 6 days. It can be applied to ESC from various strains grown under a variety of conditions. Neural progenitors can be allowed to differentiate further into functional neurons and glia or analyzed by microscopy, flow cytometry or molecular techniques. The differentiation process is amenable to time-lapse microscopy and can be combined with the use of reporter lines to monitor the neural specification process. We provide detailed instructions on media preparation and cell density optimization to allow the process to be applied to most ESC lines and a variety of cell culture vessels.

Introduction

Embryonic stem cells are pluripotent cells derived from the early embryo with the capacity to proliferate indefinitely in vitro while retaining the ability to differentiate into all adult cell types following reintroduction into an appropriate stage embryo (by forming a chimaera), injection into syngeneic or immunocompromised hosts (by forming a teratoma) or in vitro subject to appropriate cues¹. The in vitro differentiation of mouse embryonic stem cells into neural lineages was first described in 1995 and involved the formation of multicellular suspension aggregates (embryoid bodies, EBs) in serum-containing media supplemented with the morphogen retinoic acid^2-4. Since then a variety of protocols have been developed to allow neural differentiation⁵. Many still utilize aggregation, others co-culture with inducing cell types and several involve the use of serum-free media. All protocols have advantages and disadvantages and the precise nature of neural or neuronal cells produced also varies according to the protocol used.

The ideal protocol would be robust, scalable and make use of fully defined media and substrates, be amenable to non-invasive monitoring of the differentiation process and result in the generation of pure populations of neural progenitors able to be patterned by external cues and to differentiate into all neuronal and glial subtypes with high efficiency and yield in a relatively short time. In the last dozen years we have been using a method for generating neural progenitors and neurons from mouse ESC in a low density, serum-free adherent monolayer culture^6-10. This protocol fulfils many of the criteria set out above: in our hands the efficiency of differentiation has been quite consistent over many years and a variety of cell lines, it can be scaled up or down (we successfully use vessels from 96-well plates to 15 cm diameter dishes) and the media used are well-defined. The process is amenable to timelapse microscopy for the monitoring of the differentiation and a variety of patterning cues can be added to induce the generation of distinct types of neuronal subtypes (e.g., Shh and Fgf8 for dopaminergic neurons⁶).

Nevertheless, there are some challenges to the successful application of this protocol. One of the key aspects is careful preparation of the media. We always prepare the media in-house despite the availability of commercial alternatives. One of the supplements used (N2; see Protocol) has modifications over the standard commercially available versions. Finally, one of the most important steps for successful application of this method is the optimal cell density at plating. This is mainly because while the autocrine nature of one of the inducing signals (Fgf4¹¹) requires that sufficient cells are present to allow optimal viability and differentiation, at too high densities differentiation is impaired (possibly in part due to autocrine production of LIF¹²). It is therefore important that both media preparation and cell plating are performed carefully and consistently to ensure optimal results.

Protocol

1. Media Preparation

NOTE: The protocol relies on the use of a mix of two separate media: DMEM/F12 supplemented with modified N2 supplement and Neurobasal supplemented with B27 supplement, typically in a 1:1 ratio.

1. Prepare the modified N2 supplement by mixing the components in a 15 ml tube. Do not vortex or filter this; mix by inverting the tube until the solution is clear.
   1. Start by pipetting 7.2 ml of DMEM/F12, then add 1 ml of 25 mg/ml insulin (made up in 0.01 M HCl) and mix well by inverting the tube. It takes a couple of minutes until the solution is clear.
   2. Add 1 ml of 100 mg/ml apo-transferrin (made up in water), 33 µl of 0.6 mg/ml progesternone (made up in ethanol), 100 µl of 160 mg/ml (1 M) putrescine (made up in water), 10 µl of 3 mM sodium selenite (made up in water) and 666 µl of 7.5% bovine serum albumin and mix the tube well. Aliquot into 2.5 ml and store at -20 °C for up to 2 months.
2. Prepare the media.
   1. To 250 ml of DMEM/F12 add 2.5 ml of N2. Mix well but do not shake or filter.
   2. To 250 ml of Neurobasal media add 5 ml of B27 supplement. Mix well but do not shake or filter.
   3. Mix the media from steps 1.2.1 and 1.2.2 in a 1:1 ratio. In some cases a 1:3 mix may be required (supplemented as the 1:1 mix in step 1.2.4).
   4. To the mix add 0.5 ml of L-glutamine (final concentration 0.2 mM) and 3.5 µl of 2-mercaptoethanol (final concentration 0.1 mM) and mix well without shaking. Store the media at 4 °C for up to 3 weeks and avoid exposing to light. This final mix is called N2B27.
3. Prepare the gelatin solution.
   1. Prepare a 1% gelatin solution in ultrapure water and autoclave at 121 °C, 15 psi, for 15 min. It is important that the bottle used for this is completely clean from detergents or disinfectants, so it is recommended that a new bottle is used for this and is only ever rinsed in ultrapure water between uses. Aliquot the 1% solution into 50 ml aliquots and keep at 4 °C for months.
   2. Warm an aliquot of 1% gelatin in a 37 °C water bath until dissolved and add to 500 ml of warm phosphate-buffered saline (PBS). Mix well and pipet enough to cover the bottom of each well or plate. Allow the gelatin to coat the surface for at least 30 min.

2. Plating the Cells

NOTE: This protocol applies equally to mouse ESC grown in 10% serum with leukemia inhibitory factor (LIF), serum replacement with LIF or serum-free media with LIF and bone morphogenetic protein 4 (BMP4) or MEK and GSK3 inhibitors (2i media) with or without LIF. However, the timing and efficiency of the differentiation may vary depending on the media and cells (see discussion). For the experiments shown here we used the 46C mouse ESC line (that has an EGFP reporter knocked into one of the endogenous Sox1 alleles), grown in GMEM with 10% serum and LIF. For optimal results it is important that cells are dissociated and replated in the N2B27 media; simply changing of media from GMEM/serum/LIF to N2B27 always results in a reduced differentiation efficiency compared to replating the cells.

1. Grow the cells in GMEM with 10% serum, 1 mM sodium pyruvate, 1x non-essential amino acids, 0.1 M 2-mercaptoethanol, and 100 units/ml LIF¹³. To get a subconfluent culture of mouse ESC, plate 1 x 10⁶ cells into a T25 culture flask which will take 2 - 3 days.
2. Observe cells under bright-field microscope. When the cells are subconfluent and ready to passage, rinse them twice in PBS. Add 1 ml of cell dissociation reagent and return to the incubator for 2 - 5 min. Although trypsin and other enzymes can also be used for cell dissociation, they can have a negative impact on cell attachment so the plating densities will need to be adjusted.
3. Once the cells are beginning to lift from the plate, tap the vessel to dislodge them into a single cell suspension. Collect the cells into a total of 10 ml of media and cell dissociation reagent and pipet into a 15 ml centrifuge tube.
4. Spin the cells at 300 x g for 3 min at RT.
5. Carefully aspirate the supernatant and resuspend the pellet in 10 ml of pre-warmed N2B27 by pipetting up and down 3 - 5 times. When pipetting the suspension down, pipet against the side of the tube to avoid creating bubbles. Count the cells with an automated cell counter or a haemocytometer and record the concentration.
6. Prepare a cell suspension containing the desired number of cells per unit of volume to be plated per well in pre-warmed N2B27. A density of 10,500 cells per cm² in a 6-well dish (i.e., 1 x 10⁵ cells per well of a 6-well dish) is optimal. See Table 1 for suggested number of cells per cm² and plating media volumes for a variety of cell culture vessels.
7. Aspirate the gelatin from the culture vessel and plate the cell suspension according to the suggested density and volume in Table 1. Do not swirl the plates as this will concentrate the cells to the center. Place the cultures in a humid incubator at 37 °C, 5% CO₂.
8. Change media every 1 - 2 days by replacing all the media with fresh N2B27. Pipette gently as flushing the cells might affect density and lessen differentiation efficiency in the following days. Where initial viability after plating is poor, plate the cells in a 1:3 mix of the N2 and B27-supplemented media and change this to N2B27 after the first two days. Cells will begin to differentiate and should show Sox1 expression (visible by green fluorescence of the reporter in the 46C cell line used here) within 4 - 6 days.

3. Immunofluorescent Staining

NOTE: The protocol can be applied to any vessel type. The volume of each reagent is described per well of 6-well plate and can be scaled to any surface area. Replating is not recommended due to the low viability afterwards.

1. Remove differentiation medium and fix the cells by adding 500 µl of 4% (v/v) paraformaldehyde, leave for 15 min.
2. Wash and permeabilize the cells with 2 ml of PBS-T (phosphate buffered saline with 0.5% (v/v) tween-20) twice. Cells can be kept in PBS-T for up to 2 months at 4 °C.
3. Replace PBS-T with 1 ml of PBS-T with 10% (v/v) serum (from the same species as the secondary antibody). Incubate 1 hr on the plate rocker at RT to block any non-specific binding.
4. After 1 hr, wash the cells twice with 2 ml of PBS-T, and incubate in 500 µl mouse IgG against βIII-tubulin (diluted 1:1,000 in PBS-T with 10% serum). Put on the plate rocker, and leave O/N at 4 °C.
5. From this step, always protect the vessel from light. Wash the cells twice with PBS-T, then add 500 µl of fluorescence-labelled anti-mouse IgG antibody (diluted to 2 µg/ml in PBS-T with 10% serum). Put it on the plate rocker for 1 hr at RT.
6. Rinse the cells twice with PBS-T, then add 500 µl of DAPI (diluted to 0.5 µg/ml in PBS-T) and leave for 5 min.
7. Wash the cells again and keep them in PBS-T. Cells are ready to be photographed and can be kept for up to 2 weeks at 4 °C. Note that GFP signal fades over time so it is inappropriate to compare GFP intensity of fixed and live cells or of cells fixed at different times.

Results

In this experiment, we used the 46C cell line¹⁴, mouse embryonic stem cells with an endogenous Sox1-GFP reporter, to track neural differentiation. By using this cell line, expression of Sox1, a marker for neural progenitor, can be detected by green fluorescence. Plating density is a critical factor to achieve neuronal differentiation. Mouse embryonic stem cells were plated in 6-well plate at different densities varying from 10,500 to 88,500 cells/cm². Figure 1A shows differentiation...

Discussion

The monolayer neural differentiation protocol has been in use for over a decade⁶. The protocol is highly efficient, composed of defined medium, and done in a monolayer system which makes the system more applicable for preclinical (e.g., drug screening) uses. However, there are some critical factors that determine differentiation efficiency. This article points out those factors and the solution for each obstacle.

Density of the cells after plating in the differentiation con...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
Fetal bovine serum	Life Technologies	10270-106
DMEM/F12	Life Technologies	11320-074
Neurobasal medium	Life Technologies	21103-049
StemPro Accutase Cell Dissociation Reagent	Life Technologies	A11105-01
B-27 Supplement, serum free	Life Technologies	17504-044
Insulin	Sigma	I6634	Reconstitute with sterile 0.01 M HCl
Apo-transferrin	Sigma	T1147	Reconstitute with sterile water
Progesterone	Sigma	P8783	Reconstitute with ethanol
Putrescine	Sigma	P5780	Reconstitute with sterile water
Sodium selenite	Sigma	S5261	Reconstitute with sterile water
Bovine albumin fraction V	Life Technologies	15260-037
L-Glutamine	Life Technologies	25030-081	Make sure it is completely dissolved before use as glutamine is usually sedimented
Gelatine	Sigma	G1890
6-well tissue culture dish	Thermo Scientific	140675
24-well tissue culture dish	Thermo Scientific	142475
96-well tissue culture dish	Thermo Scientific	167008
GMEM	Life Technologies	11710-035
MEM Non-essential amino acids solution	Life Technologies	11140-050
Sodium pyruvate	Life Technologies	11360-070
2-mercaptoethanol	Sigma	M7522
Leukaemia inhibitory factor	prepared in-house as in Smith 1991 Journal of Tissue Culture Methods
Tween-20	Sigma	P1379
4′,6-Diamidino-2-phenylindole dihydrochloride (DAPI)	Sigma	D9542	Protect from light
Mouse anti βIII tubulin IgG antibody	Covance	MMS-435P
Fluorescence-labelled anti-mouse IgG antibody	Life Technologies	A31571	Protect from light
25 cm2 tissue culture flask	Thermo Scientific	156367